comparemela.com

Latest Breaking News On - Global investments holdings - Page 11 : comparemela.com

RE/MAX (NYSE:RMAX) Stock Price Crosses Below Two Hundred Day Moving Average of $9 44

RE/MAX Holdings, Inc. (NYSE:RMAX – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.44 and traded as low as $7.85. RE/MAX shares last traded at $7.91, with a volume of 213,275 shares traded. Wall Street Analyst Weigh In RMAX […]

CarGurus, Inc (NASDAQ:CARG) COO Samuel Zales Sells 30,000 Shares

CarGurus, Inc. (NASDAQ:CARG – Get Free Report) COO Samuel Zales sold 30,000 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $25.00, for a total value of $750,000.00. Following the sale, the chief operating officer now owns 518,845 shares in the company, […]

G-III Apparel Group (NASDAQ:GIII) Lifted to Buy at StockNews com

G-III Apparel Group (NASDAQ:GIII – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. A number of other analysts also recently weighed in on the company. TheStreet upgraded G-III Apparel Group from a “c+” rating to a “b” rating in […]

Zimmer Biomet Holdings, Inc (NYSE:ZBH) Position Lifted by Sompo Asset Management Co Ltd

Sompo Asset Management Co. Ltd. grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 15.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,960 shares of the medical equipment provider’s stock after acquiring an additional 530 shares during the […]

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Shares Purchased by Seven Eight Capital LP

Seven Eight Capital LP increased its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,906 shares of the biopharmaceutical company’s stock after acquiring an additional 26,831 shares during the quarter. Seven […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.